Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice

Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome

(2022) Vivek C. Goodoory et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions

(2022) Anne-Sophie Donnet et al.   Therapeutic Advances in Gastroenterology

Direct healthcare costs of Rome IV or Rome III ‐defined irritable bowel syndrome in the United Kingdom

(2022) Vivek C. Goodoory et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic

(2022) Hithin Noble et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Experience and clinical efficacy of gut‐directed hypnotherapy in an Asian population with refractory irritable bowel syndrome

(2022) Ayodele Sasegbon et al.   JGH Open

Six versus twelve sessions of gut-focused hypnotherapy for irritable bowel syndrome: a randomized trial

(2021) Syed S. Hasan et al.   GASTROENTEROLOGY

Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome

(2021) Vivek C. Goodoory et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

(2021) Dipesh H Vasant et al.   GUT

Review article: the effectiveness of group and self‐help hypnotherapy for irritable bowel syndrome and the implications for improving patients’ choice and access to treatment

(2021) Carolyn Gillan   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

INSIGHTS INTO THE HOLISTIC NEEDS OF PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS VIA A NURSE-LED NEUROGASTROENTEROLOGY HELPLINE SERVICE

(2021) Chee Yen Soon et al.   Gastroenterology Nursing

Stigma and irritable bowel syndrome: a taboo subject?

(2020) Mark Hearn et al.   Lancet Gastroenterology & Hepatology

Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis

(2020) Christopher J Black et al.   GUT

Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis

(2020) Priya Oka et al.   Lancet Gastroenterology & Hepatology

Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol

(2019) Dipesh H. Vasant et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Bowel Disorders

(2016) Brian E. Lacy et al.   GASTROENTEROLOGY

Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients

(2015) V. Miller et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome

(2012) P. Lindfors et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report

(2011) Douglas A Drossman et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY